LDV20 Ingredients (Berberine: Scientific Evidence for Cardiovascular Health)
What is Berberine?
Berberine is a naturally occurring alkaloid extracted from Berberis aristata and other plants in the Berberidaceae family. It has a long history of use in traditional medicine systems and has been extensively studied in modern clinical research for its role in supporting metabolic and cardiovascular health.
The Australian Register of Therapeutic Goods (ARTG) lists the berberine ingredient in LDV20 as Berberis aristata.
Key Research Findings
The following peer-reviewed studies have examined the effects of berberine supplementation:
A systematic review confirmed berberine's effectiveness in improving glycaemic control and lipid profile, supporting both metabolic and cardiovascular health.
📄 Berberine on metabolic and cardiovascular risk factors — PubMed 22780092
Research documented berberine's protective effects on heart failure, hypertension, hyperlipidaemia, insulin resistance, and arrhythmias through multiple biological pathways.
📄 Study progress of berberine for treating cardiovascular disease — PMC 5643735
A randomised, double-blind, placebo-controlled study found that a nutraceutical combination including berberine and policosanols improved lipid levels and endothelial function.
📄 Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function — PubMed 26951664
A comprehensive systematic review found berberine supplementation provides positive effects on lowering blood lipids, blood glucose, and controlling weight and blood pressure.
📄 The effects of berberine supplementation on cardiovascular risk factors — PMC 9614282
How Berberine Works in LDV20
Within the LDV20 formula, berberine and policosanol work through different metabolic pathways — berberine primarily supports LDL receptor expression while policosanol modulates cholesterol synthesis. Together with Silymarin (Milk Thistle) for liver support and Chromium for carbohydrate metabolism, these four ingredients provide complementary support for healthy metabolic balance.
For full product details, see the official LDV20 product page.
Frequently Asked Questions
What is the source of berberine in LDV20?
Berberis aristata, as listed on the ARTG record (AUST L 502251).
How does berberine complement policosanol in LDV20?
Research suggests berberine and policosanol work through different metabolic pathways, providing complementary support for healthy lipid metabolism. A clinical trial has examined their combination and reported improvements in lipid levels and endothelial function.
Is berberine safe?
Berberine has been studied in multiple clinical trials and is generally well-tolerated. Always read the label and follow the directions for use.
Where can I check the official LDV20 regulatory listing?
Visit the TGA ARTG listing for AUST L 502251 for the official regulatory record.
References
- Affuso F, et al. Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials. — PubMed 22780092
- Feng X, et al. Study progress of berberine for treating cardiovascular disease. — PMC 5643735
- Affuso F, et al. Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function. — PubMed 26951664
- Zhao JV, et al. The effects of berberine supplementation on cardiovascular risk factors: a systematic review and meta-analysis. — PMC 9614282
- Therapeutic Goods Administration. ARTG listing — AUST L 502251. — TGA ARTG 502251
Last updated: April 2026 | Prepared by: Pure Australia Editorial Team
Always read the label and follow the directions for use.
